Nuclear Diagnostic Products, Inc.

Rockaway, NJ Part of Pharmalogic Holdings Corp.

UEI
RQAKL78AXMT5
CAGE
4H4X7
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
101 Roundhill Dr, Rockaway, NJ 07866, USA
Website
ndprx.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nuclear Diagnostic Products, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Pylarify injections Contract · 36C24226P0481 Veterans Integrated Service Network 2 $3,356,110
Radiopharmaceuticals and calibration sources Contract · 36C24426P0225 Veterans Integrated Service Network 4 $174,268
Radiopharmaceuticals Contract · 36C24226N0381 Veterans Integrated Service Network 2 $959,170
Radiopharmaceuticals Contract · 36C24425N0451 Veterans Integrated Service Network 4 $374,321
VISN 2 downstate general radiopharmaceuticals - order period 3 Contract · 36C24225N0376 Veterans Integrated Service Network 2 $51,681

About Nuclear Diagnostic Products, Inc.

Written by GovTribe AI ·

Nuclear Diagnostic Products, Inc., a for-profit radiopharmaceutical manufacturer and supplier headquartered in Rockaway, New Jersey, operates as a 100% prime contractor to the Department of Veterans Affairs, delivering specialized nuclear medicine diagnostic imaging compounds — including Pylarify (Piflufolastat F 18), ILLUCCIX (Gallium 68 PSMA-11), and GA-68 NETSPOT — to VA medical facilities across the northeastern United States under full-and-open and Total Small Business set-aside delivery orders and Indefinite Delivery Contracts. The company is a subsidiary of Pharmalogic Holdings Corp.

Nuclear Diagnostic Products has maintained an established federal footprint since 2006, with 195 prime awards totaling $39.2 million in combined potential value across the past two decades. The vendor's customer base is highly concentrated within the VA system: Veterans Integrated Service Network 2 (covering New York and New Jersey) accounts for 66 awards and $20.1 million of the combined potential value, while Veterans Integrated Service Network 4 (covering Pennsylvania, New Jersey, New York, and Delaware) accounts for 21 awards and $15.5 million. Together, these two VISNs represent 92% of the vendor's combined potential value, with VISN 2 anchoring the relationship through two single-award Indefinite Delivery Contracts valued at $4.04 million and $959,170 respectively. Representative recent delivery orders include a $3.36 million Total Small Business purchase order for Pylarify injections (April 2026, ultimate completion April 2027); a $959,170 firm fixed-price delivery order for general radiopharmaceuticals to VISN 2 (February 2026); and a $374,321 delivery order modification to VISN 4 (March 2025). The vendor's top five parent vehicles — Indefinite Delivery Contracts 36C24223D0045, 36C24421D0058, VA244P0311, VA241P2090, and 36C24221D0057 — carry a combined eight to five task orders per vehicle and $2.5 million to $5.2 million in potential value per contract.

Activity accelerated from two awards in 2022 to eight in 2025, though 2026 shows four awards to date. Only three awards carry completion dates within the next twenty-four months with combined potential value of $4.5 million, indicating limited near-term recompete exposure. The vendor operates under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Medical and Surgical Instruments, Equipment, and Supplies), with 72 awards classified as medical and surgical instruments and supplies and 50 classified as drugs and biologicals. Nuclear Diagnostic Products does not subcontract; 100% of its awards are prime delivery orders and IDCs issued directly by VA regional networks for daily and bulk radiopharmaceutical supply to support positron emission tomography and single-photon emission computed tomography diagnostic procedures for veteran patients.

Quick answers

What is Nuclear Diagnostic Products, Inc.'s UEI?

Nuclear Diagnostic Products, Inc.'s Unique Entity ID (UEI) in SAM.gov is RQAKL78AXMT5.

What is Nuclear Diagnostic Products, Inc.'s CAGE code?

Nuclear Diagnostic Products, Inc.'s CAGE code is 4H4X7.

What is Nuclear Diagnostic Products, Inc.'s primary NAICS code?

Nuclear Diagnostic Products, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Nuclear Diagnostic Products, Inc. located?

Nuclear Diagnostic Products, Inc.'s physical address in SAM.gov is 101 Roundhill Dr, Rockaway, NJ 07866, USA.

Is Nuclear Diagnostic Products, Inc. registered in SAM.gov?

Yes. Nuclear Diagnostic Products, Inc.'s SAM.gov registration is active through December 22, 2026.

Who is Nuclear Diagnostic Products, Inc.'s parent company?

Nuclear Diagnostic Products, Inc. is part of Pharmalogic Holdings Corp.

What is Nuclear Diagnostic Products, Inc.'s most recent federal award?

Nuclear Diagnostic Products, Inc.'s most recent federal contract award is Pylarify injections (36C24226P0481), from Veterans Integrated Service Network 2, on April 2, 2026.

On GovTribe

See Nuclear Diagnostic Products, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login